Rights and permissions
About this article
Cite this article
Epirubicin plus tamoxifen beneficial in breast cancer. Inpharma Wkly. 1200, 18 (1999). https://doi.org/10.2165/00128413-199912000-00036
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199912000-00036